PO.BCS01.03 · 生物信息与计算
SpaceMarkers 2.0:一个用于空间转录组数据中具有空间感知能力的细胞间通讯分析框架
SpaceMarkers 2.0: A framework for spatially aware cell-cell communication in spatial transcriptomic data
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
背景:单细胞RNA测序(scRNA-seq)的一个关键局限在于细胞从组织中解离导致空间分辨率的丧失。尽管存在这一局限,目前的计算方法仍从scRNA-seq中推断细胞间相互作用,并常将结果推广到组织背景中。SpaceMarkers的开发旨在利用10x Visium直接在原位推断细胞间通讯。SpaceMarkers 2.0进一步扩展,可同时利用Visium和VisiumHD数据集,本文以来自结直肠癌(CRC)患者肿瘤及癌旁正常组织的样本进行了展示。
方法:SpaceMarkers使用空间变化的特征作为细胞活性的替代指标,并应用基于核的平滑处理来表征邻近细胞群体的“影响”。我们假设,当两种细胞状态的细胞权重和影响相互重叠时,它们会在该区域发生相互作用。使用高斯混合模型将背景值与富集值分离,以量化给定组织内的“热点”。此前,SpaceMarkers针对转录组中的单个基因推断由细胞间通讯引起的分子变化。在此,我们新增了纳入配体-受体(LR)先验知识的能力,即通过计算某一细胞群体在与其空间重叠的细胞群体影响下的配体过表达情况,来分析相互作用细胞群体对之间的配体-受体关系。我们还通过统计检验估计受体评分,以识别每个受体的细胞类型特异性。SpaceMarkers基于组织定义的相互作用区域中富集的配体评分与受体评分的几何平均数,计算聚合的LR评分。我们进一步扩展该方法,计算每个样本及分组条件下的热点重叠,并应用秩统计来识别癌组织与正常组织之间的分子程序。
结果:SpaceMarkers 2.0识别出空间热点,其中正常样本富集浆细胞至上皮细胞的信号程序,而肿瘤样本富集基质细胞与浆细胞的相互作用。在浆细胞-基质细胞交界处,我们观察到肿瘤特异性富集的成纤维细胞生长因子(FGF)配体信号,由浆细胞传向基质细胞,其中FGF23作为主导配体,与基质细胞上的FGFR4和FGFR3结合。
结论:在CRC Visium和Visium HD数据集中,该框架勾勒出肿瘤特异性的相互作用边界,并解析出哪些细胞状态在原位跨患者驱动LR轴。除CRC外,SpaceMarkers框架还可应用于其他实体瘤,从而实现对匹配条件下样本队列的比较或对癌变过程的纵向采样。总体而言,SpaceMarkers 2.0提出了一个核心框架,用于利用空间信息和多样本建模来解读肿瘤微环境中的细胞通讯。
查看英文原文 English abstract
Background: One key limitation of single cell RNA-sequencing (scRNA-seq) is the loss of spatial resolution due to the dissociation of cells from their tissue. Despite this limitation, current computational approaches infer cell-cell interactions from scRNA-seq and often generalize findings to the tissue context. SpaceMarkers was developed to infer cell-cell communication directly in-situ using 10x Visium. SpaceMarkers 2.0 is extended to leverage both Visium and VisiumHD datasets, as illustrated using samples from colorectal cancer (CRC) patient tumor and normal adjacent tissue.
Method: SpaceMarkers uses spatially varying features as proxies for cellular activity and applies kernel-based smoothing to represent the ‘influence' from cell populations in their vicinity. We hypothesize that two cell states interact in regions where their cellular weights and influence overlap. A Gaussian mixture model is used to separate background from enriched values to quantify ‘hotspots' within a given tissue. Previously, SpaceMarkers inferred molecular changes due to cell-cell communication for individual genes in the transcriptome. Here, we added the ability to incorporate prior knowledge of ligand-receptors (LR) in pairs of interacting cell populations by computing ligand overexpression within a cell population under the influence of a spatially overlapping population. We also estimate receptor scores from statistical tests to identify cell type-specificity for each receptor. SpaceMarkers calculates an aggregated LR score based on the geometric mean of the ligand and receptor score enriched in the tissue-defined interaction region. We extend this by computing per-sample and grouped condition hotspot overlaps as well as applying rank statistics to identify molecular programs between cancer and normal tissue.
Results: SpaceMarkers 2.0 identified spatial hotspots where normal samples were enriched for plasma to epithelial cell signaling programs while tumor samples were enriched for stromal and plasma cell interactions. At the plasma-stromal boundary we observed a tumor specific enrichment of fibroblast growth factor (FGF) ligand signaling from plasma cells to stromal cells, with FGF23 emerging as a dominant ligand engaging FGFR4 and FGFR3 on stromal cells.
Conclusion: In CRC Visium and Visium HD datasets, this framework delineates tumor specific interaction boundaries and resolves which cell states drive LR axes in-situ across patients. Beyond CRC, the SpaceMarkers framework can be applied to additional solid tumors, enabling comparisons in cohorts of samples in matched conditions or longitudinal sampling of carcinogenesis. Overall, SpaceMarkers 2.0 proposes a central framework for leveraging spatial information and multi-sample modeling for interpreting cellular communication in the tumor microenvironment.
利益披露 Disclosure
O. Stapleton, None..
D. Lvovs, None.